S. Grosicki
AuthID: R-00H-HMT
1
TÃTULO: Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial Full Text
AUTORES: Mateos, Maria Victoria; San Miguel, Jesus; Cavo, Michele; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Yoon, Sung Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Ngo, Mai; Katz, Eva G.; ...Mais
PUBLICAÇÃO: 2025, FONTE: LANCET ONCOLOGY, VOLUME: 26, NÚMERO: 5
AUTORES: Mateos, Maria Victoria; San Miguel, Jesus; Cavo, Michele; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Yoon, Sung Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Ngo, Mai; Katz, Eva G.; ...Mais
PUBLICAÇÃO: 2025, FONTE: LANCET ONCOLOGY, VOLUME: 26, NÚMERO: 5
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial Full Text
AUTORES: Knop, S; Mateos, MV; Dimopoulos, MA; Suzuki, K; Jakubowiak, A; Doyen, C; Lucio, P; Nagy, Z; Usenko, G; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Losava, G; Fujisaki, T; Garg, M; ...Mais
PUBLICAÇÃO: 2021, FONTE: BMC CANCER, VOLUME: 21, NÚMERO: 1
AUTORES: Knop, S; Mateos, MV; Dimopoulos, MA; Suzuki, K; Jakubowiak, A; Doyen, C; Lucio, P; Nagy, Z; Usenko, G; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Losava, G; Fujisaki, T; Garg, M; ...Mais
PUBLICAÇÃO: 2021, FONTE: BMC CANCER, VOLUME: 21, NÚMERO: 1
INDEXADO EM: Scopus WOS
Scopus WOS